ALNY Competitors
Alnylam Pharmaceuticals, Inc.
$224.47
+$0.65(+0.29%)
34
Overall
20
Value
18
Tech
65
Quality
Market Cap
$30.04B
Volume
1.11M
52W Range
$197.81 - $495.55
Target Price
$377.39
ALNY competitors: ARWR, REGN, SRPT, OPK, SNY. Alnylam Pharmaceuticals, Inc. is compared with its Healthcare peers on market cap, P/E ratio, dividend yield and performance.
ALNY Competitors Compared
| Company | Price | Market cap | EPS est. (current yr) | Dividend yield | MarketXLS Rank |
|---|---|---|---|---|---|
| ARWR Arrowhead Pharmaceuticals, Inc. | $58.37 | $8.25B | $-3.62 | - | 33 |
| REGN Regeneron Pharmaceuticals, Inc. | $778.36 | $80.14B | $47.93 | 0.48% | 59 |
| SRPT Sarepta Therapeutics, Inc. | $16.83 | $1.78B | $3.27 | - | 50 |
| OPK OPKO Health, Inc. | $1.37 | $1.02B | $-0.23 | - | 40 |
| SNY Sanofi | $39.77 | $95.41B | $5.00 | 6.08% | 60 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ALNY | $224.47 | +0.3% | 1.11M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Alnylam Pharmaceuticals, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW